Earnings Summary

Dr. Reddy's Laboratories Ltd.’s revenue jumped 16.51% since last year same period to $80162Mn in the Q3 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 4.48% jump in its revenue since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit fell -15.18% since last year same period to $12553Mn in the Q3 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -9.82% fall in its net profits since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit margin fell -27.2% since last year same period to 15.66% in the Q3 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -13.68% fall in its net profit margins since last 3-months.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.98 - a -98.75% fall from last quarter’s estimates.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.98.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -99.8% since last year same period to 0.18 in the Q3 2024. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -99.8% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Dr. Reddy's Laboratories Ltd. declared 0.48 dividend per share during the earnings announcement for Q3 2024.